NCT07823322: A Study to Evaluate INCA33890 in the Treatment of Circulating Tumor DNA-Positive Stage II/III Microsatellite Stable Colorectal Cancer After Curative Resection and Chemotherapy
- State
- Under way
- Phase
- Phase 2
- People
- 40 planned
- Started
- 14 Dec 2026
- Primary completion
- 14 May 2029
- Arms
- INCA33890
- Results
- None posted
- 16 Sep 2026: Trial registered